These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32863056)

  • 1. Re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96.
    Mahal BA; D'Amico AV; Nguyen PL
    Eur Urol; 2020 Nov; 78(5):e195. PubMed ID: 32863056
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Brandon A. Mahal, Anthony V. D'Amico, and Paul L. Nguyen's Letter to the Editor re: Neal D. Shore, Fred Saad, Michael S. Cookson, et al. Oral Relugolix for Androgen Deprivation Therapy in Advanced Prostate Cancer. N Engl J Med 2020;382:2187-96.
    Shore ND; Dearnaley D; Tombal B
    Eur Urol; 2020 Nov; 78(5):e196-e197. PubMed ID: 32838997
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer.
    Chow AK; Vourganti S; Konety BR
    Eur Urol; 2021 Sep; 80(3):386. PubMed ID: 34092438
    [No Abstract]   [Full Text] [Related]  

  • 4. Relugolix: Early Promise for a Novel Oral Androgen Deprivation Therapy with Radiation Therapy for Prostate Cancer.
    Sachdev S; Zhang H; Hussain M
    Eur Urol; 2020 Aug; 78(2):193-194. PubMed ID: 32345524
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
    Spratt DE; Dorff T; McKay RR; Lowentritt BH; Fallick M; Gatoulis SC; Flanders SC; Ross AE
    Future Oncol; 2024 Apr; 20(12):727-738. PubMed ID: 38488039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relugolix in the management of prostate cancer.
    Sahu KK; Tripathi N; Agarwal N; Swami U
    Expert Rev Anticancer Ther; 2022 Sep; 22(9):891-902. PubMed ID: 35866612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Oral Hormone for Treating Prostate Cancer.
    Aschenbrenner DS
    Am J Nurs; 2021 Apr; 121(4):22-23. PubMed ID: 33755620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relugolix in Clinical Practice: The Best Route for All?
    Cordes LM; Karzai F; Figg WD; Madan RA
    Oncologist; 2023 Aug; 28(8):647-650. PubMed ID: 37162497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Cancer 2020: "The Times They Are a'Changing".
    Paschalis A; de Bono JS
    Cancer Cell; 2020 Jul; 38(1):25-27. PubMed ID: 32663466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Matthew R. Smith, Maha Hussain, Fred Saad, et al. Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer. N Engl J Med. 2022;386:1132-1142.
    Di Lorenzo G; Buonerba C
    Eur Urol; 2022 Jul; 82(1):e17. PubMed ID: 35393160
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on "Intermittent versus continuous androgen deprivation in prostate cancer." Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr, University of Michigan, Division of Hematology/Oncology, Ann Arbor, MI. N Engl J Med 2013; 368(14):1314-25. doi: 10.1056/NEJMoa1212299.
    Eggener S
    Urol Oncol; 2014 Aug; 32(6):936-7. PubMed ID: 25087673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary on "Intermittent versus continuous androgen deprivation in prostate cancer." Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr., University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI. N Engl J Med 2013;368(14):1314-25.
    Trump DL
    Urol Oncol; 2013 Nov; 31(8):1847. PubMed ID: 24210086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relugolix (Orgovyx) for advanced prostate cancer.
    Med Lett Drugs Ther; 2023 Jul; 65(1681):e121-e122. PubMed ID: 37460145
    [No Abstract]   [Full Text] [Related]  

  • 14. Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.
    Kittai AS; Blank J; Graff JN
    Oncology (Williston Park); 2018 Dec; 32(12):599-602, 604-6. PubMed ID: 30632129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment.
    Lv J; Lin J
    Asian J Androl; 2021; 23(3):229-230. PubMed ID: 33243960
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.
    Montorsi F; Barletta F; Gandaglia G
    Eur Urol Oncol; 2023 Aug; 6(4):451. PubMed ID: 36707322
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint.
    Powell K; Burns MC; Prasad V
    Eur Urol; 2023 Feb; 83(2):101-102. PubMed ID: 36153246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen deprivation therapy for prostate cancer.
    Singer EA; Golijanin DJ; Miyamoto H; Messing EM
    Expert Opin Pharmacother; 2008 Feb; 9(2):211-28. PubMed ID: 18201145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relugolix: First Global Approval.
    Markham A
    Drugs; 2019 Apr; 79(6):675-679. PubMed ID: 30937733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.